Vitamin C and the Common Cold: Does the Pauling Myth Hold Up?

In 1970, Linus Pauling — a chemist and two-time Nobel laureate (Chemistry and Peace) — published "Vitamin C and the Common Cold," arguing that very high doses of vitamin C, far above the recommended daily amounts of the time, could dramatically reduce the frequency and severity of colds. Pauling's authority as a scientist helped the claim enter mainstream belief, where it has remained ever since, even though subsequent clinical trials from the 1970s onward produced results far more mixed than his book suggested.

The question "does vitamin C prevent colds" has received one of the most thorough evidence-based-medicine treatments around — a Cochrane systematic review, updated several times since 2007 and most recently in 2013. That review, covering dozens of clinical trials and over 11,000 participants, gives the most reliable answer to how much truth is actually in the Pauling myth.

The review's authors, Finnish researcher Harri Hemilä and Elizabeth Chalker, analyzed placebo-controlled clinical trials evaluating vitamin C in two distinct uses: regular, daily supplementation as prevention, and therapeutic use started only after the first cold symptoms appeared. This distinction matters — these are two entirely different research questions that everyday conversations about supplements often conflate.

In other words, Pauling wasn't entirely wrong — he was wrong about the scope of his claim. His observations, based partly on studies involving people under extreme exertion, may have captured a real effect that was then mistakenly generalized to the whole population. That's a common way supplement myths form: a real but narrow effect gets stretched to situations where it no longer applies.

A second, separate thread concerns shortening cold duration. Here the data is more favorable to regular supplementation — an 8% reduction in adults and 14% in children are real effects, though modest in absolute terms (with a cold typically lasting 7-10 days, this means shortening it by a few to a dozen or so hours, not days). Importantly, this effect applies only to regular supplementation started before falling ill — not reaching for vitamin C once a runny nose or sore throat has already appeared.

The leading hypothesis explaining the difference between the general population and people under extreme physical stress points to the temporary immune suppression that accompanies very intense, short-term exertion in harsh conditions — running marathons, long cross-country ski races, or military exercises in cold temperatures. Such exertion raises stress hormone levels and temporarily disrupts immune function, opening a so-called "window of susceptibility" to upper respiratory infections, well documented in sports physiology.

In practice, this means the decision to supplement with vitamin C for cold prevention should depend on who you are and what you're preparing for — for a marathon runner training in cold conditions, the data is encouraging; for someone looking for general protection against seasonal infections, far less so.

The Pauling myth is a good example of how a real but narrow scientific effect can, over time, morph into a widespread belief far broader than the data justifies. The Cochrane review doesn't debunk Pauling's claim entirely — it rather shows where its truth ends: at the boundary between the general population and people subjected to extreme, short-term physical stress.

If you're looking for a supplement "for colds" with everyday protection in mind, vitamin C isn't the strongest candidate — worth comparing it with the data on zinc, covered in a separate article. But if you're preparing for a specific, short period of extreme physical exertion, the data supports considering supplementation for that window.